We believe in forging strong bonds with our customers through delivery of products on-time, cost-effectively and securely. Quick response time, comprehensive technical support and top-notch quality products have seen Nosch record a healthy turnover of 21 million, with export sales accounting for 16.2 million.

While the product portfolio is focused on Anti-ulceratives, which contribute to 50% of the company's turnover, we also have CTDs and Technical Documentation for many products.

Since the products are manufactured right from the basic to the penultimate stage, we are strategically positioned to supply any pharmaceutical intermediates, active pharmaceutical intermediates adhering to the customers specifications.

The true prized assets at Nosch, are our people. Highly motivated and trained, they reflect a perfect blend of zeal and commitment. Sensitive to the needs of customers and proactive with solutions, they rise to meet the challenges of a constantly changing pharma world with a competitive spirit and a winner's attitude. In fact, the superior technical and innovative capabilities of our team lend us the confidence of emerging as a major player in the international arena.

As a responsible social citizen, protecting the environment is an issue that is close to our heart. We have made substantial investment in installing the latest pollution control equipment to keep pollution levels to the absolute minimum. A green belt of lush vegetation around the plants lends a scenic setting.

To conclude, we are determined to forge strong bonds with customers. Through continuous improvement in performance. Delivering pharmaceutical intermediates, active pharmaceutical intermediates that meet individual specifications. And operating in an efficient, cost-effective and quality-driven manner.

Nosch has acquired the necessary expertise to develop formulations for various products like Duloxetine Pellets, Quetiapine SR Pellets. We look forward to successfully partnering you in your formulation development projects.

At present, our R&D activities are focused on process development. The sophisticated labs, manned by a talented, well-qualified team of professionals, develop proprietary processes for organic and custom-made pharmaceutical intermediates and active pharmaceutical intermediates. The department plays an active role in the selection of new products and charting non-infringing routes for manufacturing the same.

One of the main keys to Nosch's success has been the development and launch of products at the right time, in the right form and at the right price. An operation our R&D department enables us to perform to perfection, time after time.

Nosch's manufacturing operations span across 4 units in the south Indian state of Andhra Pradesh. While two are dedicated to API Unit, the other two are for Semi-finished Formulations/ Pellets. The plants, built and operated in conformance with the latest cGMP norms, house R&D labs, technical services, quality control, quality assurance and regulatory affairs and are regularly inspected and approved by major customers from around the world.

This is the dream that drives us at Nosch. The laudable goal that we aim for. The vision that suffuses us with the passion to innovate and excel.

Over the past seven years, we have been ceaselessly engaged in a quest to sustain and improve the quality of life through creating safe pharmaceutical solutions. Our competencies have grown to embrace the entire pharmaceutical value chain - APIs, pharmaceutical intermediates, active pharmaceutical intermediates and Semi-finished Formulations.

Today, with an impeccable reputation for uncompromising quality and timely delivery, Nosch has emerged as the partner of choice of many transnational and multinational pharmaceutical companies in Asia, South America, Europe and the Middle East.